No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr15:50132400-50141200 |
Strong transcription |
Primary neutrophils fromperipheralblood |
blood
|
2 |
chr15:50135200-50181400 |
Weak transcription |
Primary mononuclear cells fromperipheralblood |
Blood
|
3 |
chr15:50135800-50187400 |
Weak transcription |
Liver |
Liver
|
4 |
chr15:50136600-50149000 |
Weak transcription |
Placenta |
Placenta
|
5 |
chr15:50137800-50141600 |
Strong transcription |
Primary monocytes fromperipheralblood |
blood
|
6 |
chr15:50138000-50146800 |
Strong transcription |
Monocytes-CD14+_RO01746 |
blood
|
7 |
chr15:50138200-50142600 |
Strong transcription |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
8 |
chr15:50138200-50145200 |
Strong transcription |
Primary hematopoietic stem cells |
blood
|
9 |
chr15:50138200-50189800 |
Strong transcription |
Primary hematopoietic stem cells short term culture |
blood
|
10 |
chr15:50138800-50142200 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
11 |
chr15:50138800-50142400 |
Enhancers |
Hela-S3 |
cervix
|
12 |
chr15:50139000-50141400 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
13 |
chr15:50139000-50142400 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
14 |
chr15:50139200-50142000 |
Enhancers |
NHLF |
lung
|
15 |
chr15:50139200-50142200 |
Enhancers |
NH-A |
brain
|
16 |
chr15:50139600-50141200 |
Flanking Active TSS |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
17 |
chr15:50139600-50141200 |
Enhancers |
HSMMtube |
muscle
|
18 |
chr15:50139600-50141400 |
Enhancers |
Colon Smooth Muscle |
Colon
|
19 |
chr15:50139600-50141400 |
Enhancers |
HSMM |
muscle
|
20 |
chr15:50140000-50141200 |
Flanking Active TSS |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
21 |
chr15:50140200-50142400 |
Enhancers |
Osteobl |
bone
|
22 |
chr15:50140200-50155600 |
Weak transcription |
Ovary |
ovary
|
23 |
chr15:50140400-50142000 |
Enhancers |
NHDF-Ad |
bronchial
|
24 |
chr15:50140600-50141400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
25 |
chr15:50140800-50141200 |
Flanking Active TSS |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
26 |
chr15:50140800-50141200 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
27 |
chr15:50140800-50141200 |
Enhancers |
Aorta |
Aorta
|
28 |
chr15:50140800-50141200 |
Enhancers |
Duodenum Smooth Muscle |
Duodenum
|
29 |
chr15:50140800-50141400 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
30 |
chr15:50140800-50141400 |
Flanking Active TSS |
A549 |
lung
|
31 |
chr15:50140800-50141600 |
Strong transcription |
Primary Natural Killer cells fromperipheralblood |
blood
|
32 |
chr15:50140800-50143800 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|